Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and...

Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call
and Webcast
CINCINNATI, July 16 /PRNewswire-FirstCall/ --

CALL DATE: Wednesday, Aug. 6, 2008
TIME: 9:30 a.m. Eastern Time
HOST: Dr. Candace Kendle, Chairman and CEO

Kendle (Nasdaq: KNDL) will conduct a telephone conference call and
simultaneous webcast on Wednesday, Aug. 6 at 9:30 a.m. Eastern Time to discuss
its financial results for the Second Quarter ended June 30, 2008. A question
and answer session will follow.
Webcast Instructions
To access the live webcast, visit the company Web site at www.kendle.com
or link to the Webcast directly at
http://www.videonewswire.com/event.asp?id=50021 . Instructions for accessing
the webcast are provided at both sites. The webcast will be archived at
http://www.kendle.com (click on "Investors" and then "Events & Presentations")
shortly after the call for on-demand replay through 5 p.m. Eastern Time on
Sept. 5, 2008. Please note that webcast participants will not be able to ask
questions.
System requirements for the webcast include Windows Media Player software
and at least a 28.8 Kbps connection to the Internet. Media Player is
downloadable at no charge from
http://www.microsoft.com/windows/windowsmedia/default.aspx .
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadian
participants should dial (800) 223-7104. Participants outside North America
should dial (706) 645-6519.
To participate in the telephone conference call, interested parties in the
United States and Canada should dial (800) 399-0069. Participants outside
North America should dial (706) 643-3694. A replay will be available through 5
p.m. Eastern Time on Sept. 5 by dialing (706) 645-9291 and entering conference
ID number 55347808.
About Kendle
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical
research organization providing the full range of early- to late-stage
clinical development services for the world's biopharmaceutical industry. Our
focus is on innovative solutions that reduce cycle times for our customers and
accelerate the delivery of life-enhancing drugs to market for the benefit of
patients worldwide. As one of the fastest-growing global providers of Phase I-
IV services, we offer experience spanning 90 countries, along with industry-
leading patient access and retention capabilities and broad therapeutic
expertise, to meet our customers' clinical development challenges. Kendle was
named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S.
investigative sites and "Best CRO" for 2007 and 2006 by leading global
pharmaceutical publication Scrip World Pharmaceutical News.
Additional information and investor kits are available upon request from
Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the
company's Web site at http://www.kendle.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
SOURCE Kendle International Inc.

Patty Frank, Investors, +1-513-763-1992, or Lori Dorer, Media,
+1-513-345-1685, both of Kendle International Inc.